Rajwana Jahan
Affiliations: | 2012-2019 | Chemistry and Biochemistry | University of Wisconsin-Milwaukee, Milwaukee, WI |
Google:
"Rajwana Jahan"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Knutson DE, Smith JL, Ping X, et al. (2020) The Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects. Acs Chemical Neuroscience |
| Witkin JM, Li G, Golani LK, et al. (2019) The positive allosteric modulator of α2/3-containing GABAA receptors, KRM-II-81, is active in pharmaco-resistant models of epilepsy and reduces hyperexcitability after traumatic brain injury. The Journal of Pharmacology and Experimental Therapeutics |
| Forkuo GS, Nieman AN, Kodali R, et al. (2019) Correction to "A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA Receptors in the Lung". Molecular Pharmaceutics |
| Witkin JM, Ping X, Cerne R, et al. (2019) The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs:The example of CERC-611 and KRM-II-81. Brain Research. 146356 |
| Berro LF, Rüedi-Bettschen D, Cook JE, et al. (2019) GABA receptor subtypes and the abuse-related effects of ethanol in rhesus monkeys: Experiments with selective positive allosteric modulators. Alcoholism, Clinical and Experimental Research |
| Witkin JM, Cerne R, Davis PG, et al. (2019) The α2,3-selective potentiator of GABA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats. Pharmacology, Biochemistry, and Behavior |
| Smith JL, Ping X, Jin X, et al. (2019) The Positive Allosteric Modulator of Alpha-2/3-Containing γ-Aminobutyric Acid Type A Receptors, KRM-II-81, Is Active in Pharmacoresistant Models of Epilepsy and in Human Epileptic Tissue Neurosurgery. 66 |
| Li G, Golani LK, Jahan R, et al. (2018) Improved Synthesis of Anxiolytic, Anticonvulsant and Antinociceptive α2/α3-GABA(A)ergic Receptor Subtype Selective Ligands as Promising Agents to Treat Anxiety, Epilepsy, as well as Neuropathic Pain. Synthesis. 50: 4124-4132 |
| Forkuo GS, Nieman AN, Kodali R, et al. (2018) A novel orally available asthma drug candidate that reduces smooth muscle constriction and inflammation by targeting GABA(A) receptors in the lung. Molecular Pharmaceutics |
| Forkuo GS, Nieman AN, Yuan NY, et al. (2017) Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABAA Receptor Modulators. Molecular Pharmaceutics |